Hims & Hers Stock Skyrockets 40% Following Landmark Weight-Loss Deal With Novo Nordisk

New York, Monday, 9 March 2026.
Ending a bitter legal feud, Novo Nordisk will now sell its blockbuster weight-loss medications through Hims & Hers, sending the telehealth platform’s stock soaring 40% in Monday trading.